Effective targeting of chronic myeloid leukemia initiating activity with the combination of arsenic trioxide and interferon alpha.
- DOI
- 10.1002/ijc.28427
- Published
- 2014 Feb 15
- Container
- International journal of cancer
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/ijc.28427,
title = {Effective targeting of chronic myeloid leukemia initiating activity with the combination of arsenic trioxide and interferon alpha.},
author = {El Eit RM and Iskandarani AN and Saliba JL and Jabbour MN and Mahfouz RA and Bitar NM and Ayoubi HR and Zaatari GS and Mahon FX and De Thé HB and Bazarbachi AA and Nasr RR},
year = {2014},
journal = {International journal of cancer},
doi = {10.1002/ijc.28427},
url = {https://doi.org/10.1002/ijc.28427}
}RIS
TY - JOUR TI - Effective targeting of chronic myeloid leukemia initiating activity with the combination of arsenic trioxide and interferon alpha. AU - El Eit RM AU - Iskandarani AN AU - Saliba JL AU - Jabbour MN AU - Mahfouz RA AU - Bitar NM AU - Ayoubi HR AU - Zaatari GS AU - Mahon FX AU - De Thé HB AU - Bazarbachi AA AU - Nasr RR PY - 2014 JO - International journal of cancer DO - 10.1002/ijc.28427 UR - https://doi.org/10.1002/ijc.28427 ER -
APA
RM, E. E., AN, I., JL, S., MN, J., RA, M., NM, B., HR, A., GS, Z., FX, M., HB, D. T., AA, B., & RR, N. (2014). Effective targeting of chronic myeloid leukemia initiating activity with the combination of arsenic trioxide and interferon alpha.. International journal of cancer. https://doi.org/10.1002/ijc.28427
Source records
- pubmed · retrieved 2026-11-10T10:24:41.937Z